Commentary on "A review of new drugs approved by the food and drug administration in 2022"

被引：0
|
作者：
Sharma, Kopal [1 ]
Sharma, Amit [2 ]
Kapadia, Rupa [1 ]
机构：
[1] SMS Med Coll & Hosp, Dept Pharmacol, Jaipur 302004, Rajasthan, India
[2] Rajasthan Dent Coll, Dept Oral & Maxillofacial Surg, Jaipur, Rajasthan, India
来源：
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE | 2024年 / 13卷 / 03期
关键词：
D O I：
10.4103/jfmpc.jfmpc_1833_23
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1133 / 1133
页数：1
相关论文
共 50 条
  • [31] Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017
    Zhu, Xingyue
    Liu, Bao
    [J]. BMJ OPEN, 2022, 12 (07):
  • [32] Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
    Alhamadani, Feryal
    Zhang, Kristy
    Parikh, Rajvi
    Wu, Hangyu
    Rasmussen, Theodore P.
    Bahal, Raman
    Zhong, Xiao-Bo
    Manautou, Jose E.
    [J]. DRUG METABOLISM AND DISPOSITION, 2022, 50 (06) : 879 - 887
  • [33] Update on Novel Drugs for Primary Care Practice: Drugs Approved by the US Food and Drug Administration in 2015
    Smetana, Gerald W.
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 164 (09) : W48 - W54
  • [34] Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration
    Molto, Consolacion
    Hwang, Thomas J.
    Borrell, Maria
    Andres, Marta
    Gich, Ignasi
    Barnadas, Agusti
    Amir, Eitan
    Kesselheim, Aaron S.
    Tibau, Ariadna
    [J]. CANCER, 2020, 126 (19) : 4390 - 4399
  • [35] A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration
    He, Qian
    Li, Qiu
    Lv, Fanzhen
    Kaitin, Kenneth I.
    Shao, Liming
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (04) : 676 - 684
  • [36] RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Cherny, Nathan I.
    Dafni, Urani
    Bogaerts, Jan
    Latino, Nicola J.
    Pentheroudakis, George
    Douillard, Jean-Yves
    Tabernero, Josep
    Zielinski, Christoph
    Piccart, Martine J.
    de Vries, Elisabeth G. E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (10)
  • [37] Mechanisms of Action of the US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
    Sang, Angela
    Zhuo, Selena
    Bochanis, Adara
    Manautou, Jose E.
    Bahal, Raman
    Zhong, Xiao-bo
    Rasmussen, Theodore P.
    [J]. BIODRUGS, 2024, 38 (04) : 511 - 526
  • [38] A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration
    Qian He
    Qiu Li
    Fanzhen Lv
    Kenneth I. Kaitin
    Liming Shao
    [J]. Therapeutic Innovation & Regulatory Science, 2021, 55 : 676 - 684
  • [39] Clinical benefit of breast cancer drugs approved by the United States Food and Drug Administration
    Carlos Tapia, J.
    Molto, Consolacion
    Bujosa, Aida
    Templeton, Arnoud J.
    Barnadas, Agusti
    Amir, Eithan
    Tibau, Ariadna
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [40] The PDR is food and drug administration approved labeling
    Oddis, JA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) : 576 - &
12345